Literature DB >> 6203493

The relation between the type of immunoreactive cells found in human papillomavirus (HPV) lesions of the uterine cervix and the subsequent behaviour of these lesions.

K Syrjänen, M Väyrynen, O Castrén, R Mäntyjärvi, M Yliskoski.   

Abstract

Human papillomavirus (HPV) lesions in the skin are rejected by immunological mechanisms, but very little is known about such mechanisms in HPV lesions of the uterine cervix. We studied the mononuclear cell infiltrates in cervical biopsies from 65 women with an HPV lesion (flat, inverted or papillomatous condyloma) who were followed for at least twelve months. We examined cryostat sections using the ANAE (acid alpha-naphthylacetate esterase) technique to demonstrate B cell, T cells, and mononuclear phagocytes (MPs), and monoclonal antibodies (OKT3, OKT4, OKT6, and OKT8) for the T cell subsets. The percentages of B-, T-, and MPs in HPV lesions with concomitant cervical intraepithelial neoplasia (CIN) were similar to those lesions without CIN. Similarly, no significant differences in cell type percentages were found in HPV lesions which regressed (n = 24), remained stationary (n = 24) or progressed (n = 3) during the follow-up period. The ratio OKT4+/OKT8+ (T helper/T suppressor, cytotoxic) cells was 1.44 and 0.81 in HPV lesions with CIN and those without CIN respectively (p less than 0.025). No statistically significant differences in that ratio were found between the lesions which remained stationary, regressed or progressed. The tendency to progress was directly related to the degree of CIN associated with HPV.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6203493     DOI: 10.1007/bf00570755

Source DB:  PubMed          Journal:  Arch Gynecol        ISSN: 0170-9925


  29 in total

1.  Spontaneous regression of plane warts after inflammation: clinical and histologic studies in 25 cases.

Authors:  H Tagami; M Takigawa; A Ogino; S Imamura; S Ofugi
Journal:  Arch Dermatol       Date:  1977-09

2.  Specific immunity to human papilloma virus (HPV) in patients with genital warts.

Authors:  J Viac; M J Staquet; M Miguet; M Chabanon; J Thivolet
Journal:  Br J Vener Dis       Date:  1978-06

3.  Histochemical identification of T and B areas in paraffin-embedded lymphoid tissues by demonstration of alpha-naphthyl acetate esterase (ANAE) activity.

Authors:  W Schlake; E M Meyer; E Grundmann
Journal:  Pathol Res Pract       Date:  1978-10       Impact factor: 3.250

4.  Histological and immunological observations on common warts in regression.

Authors:  I Brodersen; J Genner
Journal:  Acta Derm Venereol       Date:  1973       Impact factor: 4.437

5.  Strategies for generating monoclonal antibodies defining human t-lymphocyte differentiation antigens.

Authors:  P C Kung; M A Talle; M E DeMaria; M S Butler; J Lifter; G Goldstein
Journal:  Transplant Proc       Date:  1980-09       Impact factor: 1.066

6.  In vitro lymphocyte stimulation by wart antigen in man.

Authors:  L Ivanyi; W L Morison
Journal:  Br J Dermatol       Date:  1976-05       Impact factor: 9.302

7.  Immunoperoxidase demonstration of human papilloma virus (HPV) in dysplastic lesions of the uterine cervix.

Authors:  K J Syrjänen; S Pyrhönen
Journal:  Arch Gynecol       Date:  1982

8.  Warts in a pediatric renal transplant population.

Authors:  J R Ingelfinger; W E Grupe; M Topor; R H Levey
Journal:  Dermatologica       Date:  1977

9.  Immunocompetent cells in uterine cervical lesions of human papillomavirus origin.

Authors:  K J Syrjänen
Journal:  Gynecol Obstet Invest       Date:  1983       Impact factor: 2.031

10.  An in vivo study of cell-mediated immunity in human warts. Preliminary results.

Authors:  J Thivolet; M R Hegazy; J Viac; Y Chardonnet
Journal:  Acta Derm Venereol       Date:  1977       Impact factor: 4.437

View more
  5 in total

1.  CD8+ T lymphocytes are recruited to neoplastic cervix.

Authors:  M C Bell; R P Edwards; E E Partridge; K Kuykendall; W Conner; H Gore; E Turbat-Herrara; P A Crowley-Nowick
Journal:  J Clin Immunol       Date:  1995-05       Impact factor: 8.317

2.  Human papillomavirus (HPV) type as an important determinant of the natural history of HPV infections in uterine cervix.

Authors:  K Syrjanen; S Parkkinen; R Mantyjarvi; M Vayrynen; S Syrjanen; H Holopainen; S Saarikoski; O Castren
Journal:  Eur J Epidemiol       Date:  1985-09       Impact factor: 8.082

3.  Immunophenotypes of lymphocytes in prospectively followed up human papillomavirus lesions of the cervix.

Authors:  M Väyrynen; K Syrjänen; R Mäntyjärvi; O Castrén; S Saarikoski
Journal:  Genitourin Med       Date:  1985-06

4.  Human papillomavirus (HPV) DNA sequences demonstrated by in situ DNA hybridization in serial paraffin-embedded cervical biopsies.

Authors:  S Syrjänen; K Syrjänen; R Mäntyjärvi; S Parkkinen; M Väyrynen; S Saarikoski; O Castren
Journal:  Arch Gynecol       Date:  1986

5.  Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohort.

Authors:  Stina Syrjänen; Paulo Naud; Luis Sarian; Sophie Derchain; Cecilia Roteli-Martins; Adhemar Longatto-Filho; Silvio Tatti; Margherita Branca; Mojca Erzen; L S Hammes; S Costa; Kari Syrjänen
Journal:  Virchows Arch       Date:  2009-11-12       Impact factor: 4.064

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.